دورية أكاديمية

Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6.

التفاصيل البيبلوغرافية
العنوان: Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6.
المؤلفون: Concepcion, Jennifer P, Reh, Christina S, Daniels, Mark, Liu, Xiaoming, Paz, Veronica P, Ye, Honggang, Highland, Heather M, Hanis, Craig L, Greeley, Siri Atma W
المصدر: Pediatric Diabetes; Feb2014, Vol. 15 Issue 1, p67-72, 6p
مصطلحات موضوعية: DIABETES complications, HYPERGLYCEMIA, DNA, INTESTINAL diseases, DUODENAL diseases, BIOPSY, DIABETES, GALLBLADDER diseases, GENES, GENETIC mutation, PEDIATRICS, POSTOPERATIVE care, DESCRIPTIVE statistics, GENETICS, DIAGNOSIS, PHYSIOLOGY
مستخلص: Recently, bi-allelic mutations in the transcription factor RFX6 were described as the cause of a rare condition characterized by neonatal diabetes with pancreatic and biliary hypoplasia and duodenal/jejunal atresia. A male infant developed severe hyperglycemia (446 mg/ dL) within 24 h of birth. Acute abdominal concerns by day five necessitated exploratory surgery that revealed duodenal atresia, gallbladder agenesis, annular pancreas and intestinal malrotation. He also exhibited chronic diarrhea and feeding intolerance, cholestatic jaundice, and subsequent liver failure. He died of sepsis at four months old while awaiting liver transplantation. The phenotype of neonatal diabetes with intestinal atresia and biliary agenesis clearly pointed to RFX6 as the causative gene; indeed, whole exome sequencing revealed a novel homozygous RFX6 mutation c. 779A>C; p. Lys260Thr ( K260T). This missense mutation also changes the consensus 5′ splice donor site before intron 7 and is thus predicted to cause disruption in splicing. Both parents, who were not known to be related, were heterozygous carriers. Targeted genetic testing based on consideration of phenotypic features may reveal a cause among the many genes now associated with heterogeneous forms of monogenic neonatal diabetes. Our study demonstrates the feasibility of using modern sequencing technology to identify one such rare cause. Continued research is needed to determine the possible cost-effectiveness of this approach, especially when clear phenotypic clues are absent. Further study of patients with RFX6 mutations should clarify its role in pancreatic, intestinal and enteroendocrine cellular development and explain features such as the diarrhea exhibited in our case. [ABSTRACT FROM AUTHOR]
Copyright of Pediatric Diabetes is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:1399543X
DOI:10.1111/pedi.12063